ABVC Biopharma, Inc. (ABVC) Financials
ABVC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 14.5 million | 6.4 million |
| 2023-09-30 | 16.6 million | 7.5 million |
| 2023-06-30 | 9.3 million | 9.7 million |
| 2023-03-31 | 10.7 million | 9.0 million |
ABVC Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -479460 | 225739 |
| 2023-09-30 | -1.4 million | 817740 |
| 2023-06-30 | -899827 | 225740 |
| 2023-03-31 | -1.5 million | 366489 |
ABVC Net Income
No data available :(
ABVC Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | 809283 |
| 2023-09-30 | 568590 | - | 899817 |
| 2023-06-30 | 176077 | - | 999645 |
| 2023-03-31 | 1.2 million | - | 1.1 million |
ABVC Shares Outstanding
ABVC Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | 72185 | 1.8 million | - |
| 2023-09-30 | 21201 | 141310 | 2.0 million | - |
| 2023-06-30 | - | 514442 | 1.6 million | - |
| 2023-03-31 | - | 334979 | 1.6 million | - |
ABVC Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 2165 | 139206 |
| 2023-09-30 | 15884 | 29614 |
| 2023-06-30 | 6109 | 72981 |
| 2023-03-31 | 128272 | 60236 |
ABVC
Price: $1.08
52 week price:
Earnings Per Share: -2.43 USD
P/E Ratio: -0.36
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 67000
Market Capitalization: 11.4 million